Suscribirse

Diagnostic performance and relationships of structural parameters and strain components for the diagnosis of cardiac amyloidosis with MRI - 06/12/24

Doi : 10.1016/j.diii.2024.08.002 
Youssef Zaarour a, , Islem Sifaoui a, Haifa Remili a, Mounira Kharoubi b, Amira Zaroui b, Thibaud Damy b, Jean-François Deux c
a Department of Radiology, Henri Mondor University Hospital, Assistance Publique-Hopitaux de Paris, 94000 Creteil, France 
b Referral Center for Cardiac Amyloidosis, Department of Cardiology, Mondor Amyloidosis Network, GRC Amyloid Research Institute, CHU Henri Mondor, 94000 Creteil and Université Paris Est Creteil, INSERM Unit U955, Team 8, Paris-Est Creteil University, Créteil, France 
c Department of Radiology, Geneva University Hospitals, 1205, Geneva, Switzerland 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Extracellular volume outperforms feature-tracking myocardial strain components for the diagnosis of cardiac amyloidosis with cardiac MRI.
Feature-tracking global radial strain compares favorably with native myocardial T1 for the diagnosis of cardiac amyloidosis using cardiac MRI.
With the exception of extracellular volume, the combination of feature tracking with global radial strain and basal native myocardial T1 provides best performances (AUC = 0.905) for the diagnosis of cardiac amyloidosis with 82% sensitivity and 90% specificity using cardiac MRI.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to evaluate the diagnostic performance and relationships of cardiac MRI structural parameters and strain components in patients with cardiac amyloidosis (CA) and to estimate the capabilities of these variables to discriminate between CA and non-amyloid cardiac hypertrophy (NACH).

Materials and methods

Seventy patients with CA (56 men; mean age, 76 ± 10 [standard deviation] years) and 32 patients (19 men; mean age, 63 ± 10 [standard deviation] years) with NACH underwent cardiac MRI. Feature tracking (FT) global longitudinal strain (GLS), radial strain (GRS), circumferential strain (GCS), strain AB ratio (apical strain divided by basal strain), myocardial T1, myocardial T2 and extracellular volume (ECV) were calculated. Comparisons between patients with CA and those with NACH were made using Mann-Whitney rank sum test. The ability of each variable to discriminate between CA and NACH was estimated using area under the receiver operating characteristic curve (AUC).

Results

Patients with CA had higher median GLS (-7.0% [Q1, -9.0; Q3, -5.0]), higher median GCS (-12.0% [Q1, -15.0; Q3, -9.0]), and lower median GRS (16.5% [Q1, 13.0; Q3, 23.0]) than those with NACH (-9.0% [Q1, -11.0; Q3, -8.0]; -17.0% [Q1, -20.0; Q3, -14.0]; and 25.5% [Q1, 16.0; Q3, 31.5], respectively) ( P < 0.001 for all). Median myocardial T1 and ECV were significantly higher in patients with CA (1112 ms [Q1, 1074; Q3, 1146] and 47% [Q1, 41; Q3, 55], respectively) than in those with NACH (1056 ms [Q1, 1011; Q3, 1071] and 28% [Q1, 26; Q3, 30], respectively) ( P < 0.001). Basal ECV showed the best performance for the diagnosis of CA (AUC = 0.975; 95% confidence interval [CI]: 0.947–1). No differences in AUC were found between AB ratio of GRS (0.843; 95% CI: 0.768–0.918) and basal myocardial T1 (0.834; 95% CI: 0.741–0.928) for the diagnosis of CA ( P = 0.81). The combination of the AB ratio of FT-GRS and basal myocardial T1 had a diagnostic performance not different from that of basal ECV ( P = 0.06).

Conclusion

ECV outperforms FT-strain for the diagnosis of CA with cardiac MRI. The AB ratio of FT-GRS associated with myocardial T1 provides diagnostic performance similar to that achieved by ECV.

El texto completo de este artículo está disponible en PDF.

Keywords : Cardiac amyloidosis, Cardiac MRI, Extracellular volume, Feature-tracking strain, Hypertrophic cardiomyopathy

Abbreviations : AB, AL, AUC, ATTR, CA, CI, ECV, FT, GCS, GLS, GRS, ICC, MRI, NACH, SD


Esquema


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 105 - N° 12

P. 489-497 - décembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Comparison between contrast-enhanced fat-suppressed 3D FLAIR brain MR images and T2-weighted orbital MR images at 3 Tesla for the diagnosis of acute optic neuritis
  • Sharmiladevi Manasse, Patricia Koskas, Julien Savatovsky, Romain Deschamps, Catherine Vignal-Clermont, Marine Boudot de la Motte, Caroline Papeix, Stéphanie Trunet, Augustin Lecler
| Artículo siguiente Artículo siguiente
  • Flow quantification within the aortic ejection tract using 4D flow cardiac MRI in patients with bicuspid aortic valve: Implications for the assessment of aortic regurgitation
  • Lan-Anh Nguyen, Umit Gencer, Guillaume Goudot, Damian Craiem, Mariano E. Casciaro, Charles Cheng, Emmanuel Messas, Elie Mousseaux, Gilles Soulat

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.